share_log

GlaxoSmithKline | 6-K: Gsk Delivers Strong 2023 Performance and Upgrades Growth Outlooks

SEC ·  Jan 31, 2024 18:02
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more